Raja-Elie E Abdulnour, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Lung Injury | 4 | 2019 | 377 | 1.080 |
Why?
|
| Docosahexaenoic Acids | 6 | 2021 | 915 | 0.990 |
Why?
|
| Hydrochloric Acid | 2 | 2019 | 76 | 0.790 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2018 | 2270 | 0.690 |
Why?
|
| Phospholipase D | 1 | 2018 | 71 | 0.580 |
Why?
|
| Blood Platelet Disorders | 1 | 2018 | 60 | 0.580 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 319 | 0.530 |
Why?
|
| Leukocytes | 3 | 2019 | 2034 | 0.520 |
Why?
|
| Lung | 8 | 2019 | 10068 | 0.490 |
Why?
|
| Education, Medical | 2 | 2024 | 1744 | 0.440 |
Why?
|
| Neutrophils | 5 | 2021 | 3782 | 0.400 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 518 | 0.380 |
Why?
|
| Pseudomonas Infections | 1 | 2015 | 622 | 0.370 |
Why?
|
| Aspirin | 3 | 2016 | 3134 | 0.350 |
Why?
|
| Phagocytosis | 3 | 2019 | 1526 | 0.290 |
Why?
|
| Clinical Competence | 1 | 2022 | 4858 | 0.260 |
Why?
|
| Xanthine Oxidase | 1 | 2006 | 69 | 0.260 |
Why?
|
| Lipoxins | 2 | 2018 | 419 | 0.240 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 18329 | 0.240 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2018 | 539 | 0.220 |
Why?
|
| Blood Platelets | 1 | 2014 | 2465 | 0.220 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 616 | 0.220 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2015 | 757 | 0.210 |
Why?
|
| Neuropeptides | 2 | 2019 | 950 | 0.210 |
Why?
|
| Pneumonia | 3 | 2024 | 2161 | 0.210 |
Why?
|
| Lung Diseases | 2 | 2018 | 1940 | 0.200 |
Why?
|
| Radiation Pneumonitis | 1 | 2023 | 100 | 0.200 |
Why?
|
| Hypersensitivity | 3 | 2021 | 1168 | 0.180 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 1674 | 0.180 |
Why?
|
| Neutrophil Activation | 1 | 2021 | 180 | 0.180 |
Why?
|
| Inflammation | 4 | 2024 | 10863 | 0.180 |
Why?
|
| Lymphocytes | 2 | 2019 | 2606 | 0.180 |
Why?
|
| Respiratory Mucosa | 2 | 2021 | 437 | 0.170 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2019 | 31 | 0.170 |
Why?
|
| Pulmonary Edema | 3 | 2011 | 409 | 0.160 |
Why?
|
| Receptors, IgE | 1 | 2021 | 375 | 0.160 |
Why?
|
| Leukotriene Antagonists | 1 | 2019 | 124 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 1492 | 0.160 |
Why?
|
| Health Facilities | 1 | 2024 | 578 | 0.160 |
Why?
|
| Mice | 16 | 2024 | 81898 | 0.150 |
Why?
|
| Education, Distance | 1 | 2022 | 260 | 0.150 |
Why?
|
| Leukotrienes | 1 | 2019 | 232 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 8 | 2019 | 22351 | 0.140 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2019 | 327 | 0.140 |
Why?
|
| Sepsis | 2 | 2021 | 2604 | 0.130 |
Why?
|
| Gene Expression | 3 | 2021 | 7585 | 0.130 |
Why?
|
| Nociceptors | 2 | 2021 | 460 | 0.130 |
Why?
|
| Bronchi | 1 | 2019 | 847 | 0.120 |
Why?
|
| Cytoprotection | 1 | 2015 | 199 | 0.120 |
Why?
|
| Monocytes | 2 | 2021 | 2599 | 0.120 |
Why?
|
| Cysteine | 1 | 2019 | 896 | 0.120 |
Why?
|
| Platelet Activating Factor | 1 | 2014 | 142 | 0.120 |
Why?
|
| Language | 1 | 2024 | 1550 | 0.120 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 1349 | 0.120 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2014 | 82 | 0.110 |
Why?
|
| Airway Remodeling | 1 | 2015 | 133 | 0.110 |
Why?
|
| Animals | 17 | 2024 | 168939 | 0.110 |
Why?
|
| Macrophages | 2 | 2019 | 5784 | 0.110 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2015 | 271 | 0.110 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 789 | 0.110 |
Why?
|
| Ventilators, Mechanical | 2 | 2006 | 292 | 0.110 |
Why?
|
| Macrophages, Alveolar | 1 | 2015 | 413 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 1889 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1716 | 0.100 |
Why?
|
| Asthma | 2 | 2024 | 6266 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 665 | 0.100 |
Why?
|
| Double-Blind Method | 3 | 2023 | 12430 | 0.100 |
Why?
|
| Immunity, Innate | 4 | 2019 | 3079 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 661 | 0.100 |
Why?
|
| Thrombin | 1 | 2014 | 600 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2021 | 14473 | 0.100 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 661 | 0.100 |
Why?
|
| Platelet Transfusion | 1 | 2014 | 301 | 0.100 |
Why?
|
| Bronchial Spasm | 1 | 2011 | 71 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2014 | 1882 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2018 | 2493 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2662 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2016 | 6225 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 1399 | 0.080 |
Why?
|
| Male | 18 | 2024 | 364154 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2019 | 18986 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2015 | 1276 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1895 | 0.070 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2010 | 418 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2014 | 1814 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5690 | 0.070 |
Why?
|
| Ovalbumin | 2 | 2021 | 677 | 0.070 |
Why?
|
| Th2 Cells | 2 | 2024 | 1077 | 0.070 |
Why?
|
| Humans | 20 | 2024 | 766812 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 209 | 0.060 |
Why?
|
| Thalassemia | 1 | 2006 | 267 | 0.060 |
Why?
|
| Capillary Permeability | 2 | 2006 | 772 | 0.060 |
Why?
|
| Metabolomics | 1 | 2014 | 1674 | 0.060 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 418 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6507 | 0.060 |
Why?
|
| Lipids | 1 | 2015 | 3322 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4747 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5502 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2011 | 1359 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2015 | 4211 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2006 | 744 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4880 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 694 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 911 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15912 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 3114 | 0.050 |
Why?
|
| Female | 11 | 2024 | 396532 | 0.050 |
Why?
|
| Immunologic Tests | 1 | 2021 | 101 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2006 | 709 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3587 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22248 | 0.040 |
Why?
|
| Substance P | 1 | 2021 | 331 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2006 | 1090 | 0.040 |
Why?
|
| Leukocyte Elastase | 1 | 2019 | 113 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 7612 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 949 | 0.040 |
Why?
|
| Prednisone | 1 | 2023 | 1566 | 0.040 |
Why?
|
| Vagus Nerve | 1 | 2021 | 458 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 472 | 0.040 |
Why?
|
| Neuroimmunomodulation | 1 | 2019 | 186 | 0.040 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2017 | 171 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2024 | 1895 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 481 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 260 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2006 | 2714 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2019 | 562 | 0.030 |
Why?
|
| Middle Aged | 5 | 2021 | 223267 | 0.030 |
Why?
|
| Vitamins | 1 | 2024 | 1631 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2019 | 1606 | 0.030 |
Why?
|
| Adult | 6 | 2020 | 223305 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 1560 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2015 | 144 | 0.030 |
Why?
|
| Aged | 4 | 2020 | 171344 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2015 | 179 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 268 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2015 | 303 | 0.030 |
Why?
|
| Capsaicin | 1 | 2015 | 233 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1791 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 4424 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2024 | 12985 | 0.030 |
Why?
|
| Triage | 1 | 2020 | 995 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 734 | 0.030 |
Why?
|
| Allergens | 1 | 2021 | 1436 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 6491 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 828 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2021 | 23618 | 0.020 |
Why?
|
| Lidocaine | 1 | 2015 | 545 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2017 | 923 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2014 | 548 | 0.020 |
Why?
|
| Laryngismus | 1 | 2010 | 28 | 0.020 |
Why?
|
| Ligands | 1 | 2017 | 3274 | 0.020 |
Why?
|
| Vitamin D | 1 | 2024 | 3270 | 0.020 |
Why?
|
| Time Factors | 2 | 2016 | 40149 | 0.020 |
Why?
|
| Cytokines | 2 | 2015 | 7438 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 2062 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2677 | 0.020 |
Why?
|
| Laryngeal Masks | 1 | 2010 | 118 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5022 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 1005 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 21527 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15831 | 0.020 |
Why?
|
| Calcium | 1 | 2021 | 5783 | 0.020 |
Why?
|
| Positive-Pressure Respiration | 1 | 2011 | 713 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 1691 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 7870 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4277 | 0.020 |
Why?
|
| Physicians | 1 | 2024 | 4591 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2010 | 702 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2024 | 5367 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13642 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 59548 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 15564 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10451 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 513 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 4559 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 26309 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11062 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 9546 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16722 | 0.010 |
Why?
|
| Neurons | 1 | 2021 | 9515 | 0.010 |
Why?
|
| Acute Disease | 1 | 2010 | 7240 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 11924 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 18076 | 0.010 |
Why?
|
| Echocardiography | 1 | 2011 | 5038 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2011 | 6408 | 0.010 |
Why?
|
| United States | 1 | 2016 | 72945 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4570 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4143 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59939 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39312 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20710 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 65286 | 0.000 |
Why?
|
| Adolescent | 1 | 2006 | 88902 | 0.000 |
Why?
|